Osage University Partners (OUP) is a Pennsylvania venture capital firm founded in 2009.
OUP seeks to invest in companies founded by scientists, academics and students in software, hardware, therapeutics, medical devices and diagnostics sectors.
The company's portfolio includes Artizan Biosciences, Cleave Therapeutics, Cyteir Therapeutics, Everactive, IonQ, Landos Biopharma, Menlo Security, Menlo Security, PMV Pharmaceuticals and SiFive, etc.
OUP manages $600M and is investing out of a $273M fund as of November 2019.
Osage University Partners Raises Third Fund For University Research Spinouts